Christina M. Coughlin, Chief Medical Officer at Rubius Therapeutics, Inc. (RUBY), bought 38,000 shares at $5.52 ($210K) on 2020-04-22, disclosed to the SEC on 2020-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.52 | 19,000 | $105K | 50.0% |
| 2 | $5.52 | 19,000 | $105K | 50.0% |
| Total | $5.52 avg | 38,000 | $210K | 100% |